NRC — Cell Culture Pilot Plant ### 📋 Eligible Entities - Biopharmaceutical companies developing biologics and vaccines - Small to medium-sized enterprises (SMEs) in the life sciences sector - Biotech startups requiring pilot-scale manufacturing capabilities - Academic institutions and research organizations commercializing cell culture technologies - Contract manufacturers seeking cell culture development services - Companies lacking in-house cell culture infrastructure and pilot plant capacity Note: This is a fee-for-service facility rather than a grant program with equity requirements; entities must have legitimate biologics or vaccine development projects. ### 💰 Funding Details - Structure: Fee-for-service model (not a traditional grant) - Cost Basis: Users pay for access to NRC's cell culture pilot plant facilities and expertise - Pricing: Tiered rates based on: - Duration of facility usage - Complexity of scale-up project - Level of technical support required - Equipment and consumables consumed - No Repayment Required: Service fees paid directly to NRC; no loan component - Potential Cost Sharing: Organizations may negotiate volume discounts or partnership arrangements with NRC ### 🛠️ Approved Expenses - Cell line development and optimization (CHO, HEK 293, and other animal cell systems) - Process development for biologics and vaccine production - Scale-up activities from bench to pilot plant scale - Cell culture media formulation and testing - Bioreactor operation and monitoring - Product purification and downstream processing support - Quality control and analytical testing - GMP-compliant manufacturing support (where applicable) - Technical consulting from NRC cell culture experts - Consumables and materials used during pilot production runs ### ⚠️ Conditions & Milestones - Project Scope Definition: Organizations must clearly define their cell culture development objectives and scale-up requirements upfront - Technical Assessment: NRC conducts feasibility review to confirm project suitability for available systems (CHO, HEK 293, etc.)
About this program
Fee-for-service cell culture pilot plant offering development and scale-up for the production of biologics and vaccines using CHO, HEK 293 and other animal cell expression systems.
Ask AI about this Grant
Instant Eligibility Answers
Eligibility Match
Log in to automatically cross-reference this grant against your business profile and province.Check Compatibility